Nektar Therapeutics Stock Price $38.23 +0.04 (0.10%)

Nektar Therapeutics, is a Health Care stock that trades on the NASDAQ and has a market capitalization of $6.40 Billion.


Nektar Therapeutics Stock Charts

The 5 year and 1 year stock charts are below.


50 Day Moving Average

The 50 Day Moving Average is at $48.61 which is 21.35% above the stock price of $38.23.

200 Day Moving Average

The 200 Day Moving Average is at 68.01 which is 43.79% abovethe stock price of $38.23.


NKTR Stock Price

Below are a few key dates for the stock price.


Year To Date

Nov
16
Friday

The most recent stock price is $38.23.

The Year To Date (YTD) return is -33.69%.

52 Week Low

Nov
09
Friday

The 52 Week Low stock price is $33.50 set on Fri, Nov 9, 2018 which is 8 days ago.

The current price per share is 14.12% above the 52 week low.

52 Week High

Mar
12
Monday

The 52 Week High stock price is $111.36 set on Mon, Mar 12, 2018 which is 250 days ago.

The current price per share is -65.67% below the 52 week high.

All Time High

Mar
12
Monday

The All Time High stock price is $111.36 set on Mon, Mar 12, 2018 which is 250 days ago.

The current price per share is -65.67% below the all time high.

Earnings

Below is the EPS, P/E Ratio and Earnings Date.


The Earnings Per Share (EPS) is $5.38.

The Price To Earnings (P/E) Ratio is 7.26.

Earnings Dates

Stocks can make big percentage moves on the earnings announcement.

Companies announce earnings either before the market open or after the close.

Aug
08
Wednesday

The Earnings Release Date for Nektar Therapeutics was Wed, Aug 8, 2018.

Since this earnings release 101 days ago, the stock price is down by -30.01%.

Nov
07
Wednesday

The most recent Earnings Release Date was on Wed, Nov 7, 2018, which was 10 days ago.

Since this earnings date, the stock price is up by +5.96%.

Nektar Therapeutics Dividend

Below is important Dividend information.


NKTR currently does not pay a dividend.

You may like this list of best dividend stocks of 2018.

Industry Stocks

Below are other Biotech & Pharma stocks as Nektar Therapeutics.